In the rapidly evolving landscape of healthcare, genetic testing is emerging as a pivotal force, promising to transform patient care through precision medicine. The insights derived from our genetic codes hold the potential to not only prevent diseases but also optimize treatments and promote healthier living. Yet, as highlighted in a recent MedCity News article, the journey towards realizing this potential is fraught with challenges, particularly around patient privacy and data sharing.
The Role of Information Technology
A critical component in addressing these challenges is information technology security. Organizations are turning to certifications like HITRUST to establish standards for safeguarding sensitive information. By aligning with these standards, they can protect data while facilitating the sharing necessary to enhance medical knowledge and patient care.
Collaborative Efforts and Data Sharing
Collaboration is at the heart of advancing genetic testing. Companies are contributing de-identified variant data to public health databases such as ClinVAR and the SEER Cancer Registries. These efforts, supported by cancer research registries, deepen insights and expedite advancements in patient care.
The analysis of expansive data sets is crucial for understanding diseases, allowing researchers to access, assess, and test hypotheses. This collaborative approach is paving the way for tailored treatment plans and new biological discoveries, enhancing early disease detection and intervention.
Integration with Electronic Health Records
Integrating genetic testing with Electronic Health Records (EHR) is another key strategy for improving patient outcomes. Collaborations with EHR vendors like Epic, Flatiron, and Athena streamline processes, making it easier for providers to order genetic products, optimize screening protocols, and identify potential pharmacogenetic interactions. Such collaborations break down silos, enhancing data exchange for more effective research and patient care.
Challenges and Future Trends
Despite the promising progress, the integration of genetic testing into mainstream medicine presents challenges, including managing the vast volume of genomic data. Companies are focusing on presenting complex clinical interpretations, integrating common data ontologies, overcoming data fragmentation, and ensuring data privacy to address these hurdles.
Looking ahead, the industry anticipates significant advancements, with trends like developing tests for early cancer recurrence detection and embracing a multi-omics approach that integrates RNA, proteins, and AI insights. The integration of generative AI for documentation and genetic counseling is another notable development on the horizon.
A New Era in Healthcare
Genetic testing represents more than just a scientific advancement; it signifies a fundamental shift in how we approach health and wellness. As public understanding grows and technology advances, we find ourselves at the dawn of a new era in healthcare, where our genetic code becomes a roadmap to better health and longevity.
About the Author
Kevin Haas, Ph.D., serves as the Chief Technology Officer at Myriad Genetics, where he leads the development of the precision medicine platform. With expertise in molecular simulation and machine learning, Haas is advancing genomics and digital patient/provider experiences. He has co-authored 16 peer-reviewed publications and nine patent applications, bringing a wealth of experience to his role.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Lofty has launched the industry’s first Agentic AI Operating System, a breakthrough platform that doesn’t just follow commands—it plans, executes, evaluates, and adapts entire workflows on its own. Designed specifically for real estate professionals, the system acts like an AI “orchestra,” coordinating specialized agents for lead qualification, marketing, SEO, transaction management, website creation, and more. With leaders calling this a major leap beyond traditional tools, Lofty AOS signals a new era where agents can focus on relationships and closings while AI handles the heavy lifting.
Florida’s insurance landscape is finally showing signs of stability as private insurers return and Citizens Property Insurance drops below 400,000 policies. Insurance Commissioner Michael Yaworsky says reforms are working, but homeowners may not feel relief yet as inflation and rebuilding costs keep premiums high. With transparency improvements, mitigation credits, and new AI regulations on the horizon, Florida aims to avoid another insurance crisis while keeping the market competitive and consumer‑friendly.
Mortgage rates just hit their lowest point since 2022, closing January at 6.18% and giving buyers and industry professionals a rare moment of relief. But while the Federal Reserve continues to pause rate hikes, economists warn that significant declines are unlikely. Most forecasts show rates hovering near 6% through 2026, with political uncertainty and inflation keeping markets volatile. For now, stability may be the best we get — and even that could be temporary.
Propy, a fast-growing real estate tech firm blending AI automation with blockchain-backed transaction systems, has secured a major $100 million credit facility to accelerate nationwide title company consolidation. The funding aims to modernize the traditionally slow, paper-heavy closing process, offering real estate professionals a faster, more secure, and more transparent experience. As automation reshapes the industry, staying educated on emerging technology will be essential for agents, brokers, mortgage professionals, and investors looking to stay competitive.
Escrow payments in Florida have jumped an astonishing 70% since 2019, far outpacing the national average and now consuming nearly 38% of a typical monthly mortgage payment. Surging insurance premiums and rising property taxes are driving the increase, reshaping affordability for homeowners and pricing out many would‑be buyers.
After losing their Altadena home in the LA wildfires, Jessica and Matt Conkle expected State Farm to help them rebuild. Instead, they faced months of delays, low valuations, and stalled claims — a struggle shared by nearly 80 percent of wildfire survivors. As insurers pull out of high‑risk areas and premiums soar, the crisis is reshaping homeownership, tightening mortgage approvals, and straining government safety nets. What’s happening in California is rapidly becoming a national issue, with real estate, mortgage, and insurance professionals on the front lines of a system under unprecedented pressure.
